文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

限制型与浸润型心肌病谱系:两篇系列之第二篇

Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

限制型心肌病是最少见的心肌病类型,分为浸润型、非浸润型、贮积病和心内膜心肌病。遗传性疾病常见于儿童或青少年,但越来越多射血分数保留的心力衰竭老年患者被识别出限制型心肌病,尤其是心脏淀粉样变性。无创评估已取代心内膜心肌活检用于大多数疑似病因的诊断,检出浸润型心肌病(如原发性和继发性铁过载及结节病等炎症性疾病)可通过疾病特异性治疗改善结局。

要点

  • 限制型心肌病分为浸润型、非浸润型、贮积病和心内膜心肌病。
  • 老年HFpEF患者中限制型心肌病(尤其心脏淀粉样变性)的识别率增加。
  • 无创评估已取代活检用于大多数疑似病因诊断,疾病特异性治疗可改善结局。

核心结论

  • 限制型心肌病虽少见,但在老年HFpEF人群中识别率增加,无创评估和疾病特异性治疗可改善部分浸润型心肌病结局。

研究设计与样本

  • 综述(J Am Coll Cardiol),纳入限制型与浸润型心肌病的分类、诊断与治疗进展。

主要发现

  • 限制型心肌病分为浸润型、非浸润型、贮积病和心内膜心肌病。
  • 遗传性疾病常见于儿童或青少年。
  • 越来越多老年HFpEF患者被识别为限制型心肌病,尤其是心脏淀粉样变性。
  • 检出浸润型心肌病(如原发性和继发性铁过载及结节病等炎症性疾病)可通过疾病特异性治疗改善结局。

关键数值与推荐

  • 无创评估已取代心内膜心肌活检用于大多数疑似限制型心肌病病因的诊断。

临床怎么用

  • 对疑似限制型心肌病应首选无创评估,识别浸润型病因以启动疾病特异性治疗。
  • 在老年HFpEF患者中需警惕限制型心肌病,尤其心脏淀粉样变性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Restrictive cardiomyopathies are the least common form of heart muscle disease. They are characterized as infiltrative and noninfiltrative, storage diseases, and endomyocardial disorders. Genetic diseases commonly present during childhood or adolescence. However, a growing percentage of elderly patients with heart failure with preserved ejection fraction are being recognized as having forms of restrictive cardiomyopathy, particularly cardiac amyloidosis. Noninvasive evaluation has replaced endomyocardial biopsy in the diagnostic evaluation of most suspected etiologies. The detection of infiltrative cardiomyopathies, particularly primary and secondary forms of iron overload, as well as inflammatory diseases such as sarcoidosis has slowly led to improved outcomes via disease-specific therapies.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Pereira NL, Grogan M, Dec GW, et al. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 2 of a 2-Part Series. J Am Coll Cardiol. 2018. PMID: 29519356. doi:10.1016/j.jacc.2018.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。